BTMD - CIK 0001819253
The table below shows biote Corp.'s cash flow statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $35.19M | $45.24M | $26.88M | -$9.16M | $33.72M |
| Capital expenditure | $5.01M | $6.43M | $359.00K | $333.00K | $1.45M |
| Investing cash flow | -$6.86M | -$18.80M | -$2.71M | -$1.84M | -$3.81M |
| Dividends paid | $1.73M | $4.74M | $8.69M | $12.89M | $11.40M |
| Stock buybacks | $3.37M | $5.60M | - |
biote Corp. reported operating cash flow of $35.19M for fiscal year 2025. That is down 22.2% from $45.24M in fiscal 2024. Over the 5 fiscal years shown, operating cash flow grew from $33.72M (FY 2021) to $35.19M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Financing cash flow | -$43.55M | -$76.08M | -$14.38M | $63.46M | -$20.34M |